Vivos Inc (RDGL)

[SC8]

First, share count was 333,749,694 on July 1 2021, less than two years ago. Then you're not counting the warrants. RDGL just sold more than 5% of company (was about 19 million shares counting warrants) at $0.078 average to only raise about 3 months worth of cash at $2.5 million burn rate for 2021 and 2022.

Point is RDGL doesn't have forever to get Radiogel to human trials, yet IDE submission seems several months away at best. MK has never been proactive dealing with FDA. He still has that bogus statement up on Twitter: "Our (PRnT) device is currently undergoing review with the @US_FDA."

There's nothing for FDA to consider until RDGL submits the IDE application.